Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Bridwell Mark REVP, GC and Secretary |  RYNRAYONIER INCOpen-market sale | SELL | $107K 5,318 sh | Sep 11, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Bridwell Mark REVP, GC and Secretary | RYNRAYONIER INC Open-market sale | SELL | $107K 5,318 sh | Sep 11, 2026 |
| 24 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $5.19M 15.8K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 23 | ten Bosch John RoderickSVP of Laboratory Operations |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $138K 1,416 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 23 | Taich AdamChief Financial Officer |  TXG10x Genomics, Inc.Open-market sale · 10b5-1 plan | SELL | $2.02M 31.4K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 22 | Evans Katie SeitzSee Remarks |  MGNIMAGNITE, INC.Open-market sale · 10b5-1 plan | SELL | $336K 14.0K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $108K 1,285 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 21 | Craddock John Mitchell Jr.Chief Operating Officer |  SBSISOUTHSIDE BANCSHARES INCOpen-market sale | SELL | $13K 415 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 21 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $2.15M 24.4K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 21 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $260K 800 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 21 | Jenkins JerrySVP, CHRO |  GETYGetty Images Holdings, Inc.Open-market sale | SELL | $588 2,558 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 21 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $429K 1,300 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 19 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $285K 1,360 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $584K 2,800 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $303K 1,440 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $914K 4,400 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $403K 1,920 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $418K 2,000 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $303K 1,431 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 18 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $652K 7,171 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 17 | Kerr Michael SGeneral Counsel |  QTWOQ2 Holdings, Inc.Open-market sale | SELL | $39K 636 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 16 | Briggs TeresaDirector |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $35K 548 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Taich AdamChief Financial Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $898K 13.8K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 1,169 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 360 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $93K 440 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $196K 920 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 16 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 1,160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 15 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $525K 468.7K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 15 | Tak Paul PeterDirector, Chief Executive Officer |  CADLCandel Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $621K 59.4K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 14 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $179K 10.2K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 80 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 120 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Taich AdamChief Financial Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 1,206 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 13 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 200 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 1,100 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,630 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 10 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $1.97M 20.5K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer | OCGNOcugen, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |